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Abstract
The type I interferon (IFN) response requires the coordinated activation of the latent transcription factors NF-κB, IRF-3 and ATF-2 which in turn
activate transcription from the IFN-β promoter. Here we have examined the type I interferon response in rhinovirus type 14-infected A549 cells, with
particular emphasis on the status of the transcription factor IRF-3. Our results indicate that although rhinovirus type 14 (RV14) infection induces the
activation of NF-κB andATF-2, only very low levels of IFN-βmRNAare detected. Analysis of ISG54mRNA levels revealed very little induction of this
IRF-3 responsive transcript and suggested that IRF-3 activation might be impaired. Examination of IRF-3 in RV14-infected cells demonstrated only low
levels of phosphorylation, a lack of homodimer formation and an absence of nuclear accumulation indicating that this transcription factor is not activated.
Inhibition of viral protein synthesis following infection resulted in an increase in IFN-βmRNA levels indicating that viral gene products prevent induction
of this pathway. Collectively, these results indicate that RV14 infection inhibits the host type I interferon response by interfering with IRF-3 activation.
© 2008 Elsevier Inc. All rights reserved.Keywords: Rhinovirus; IRF-3; Innate immune response; Type I interferon response; Picornavirus; Interferon-βIntroduction
Rhinoviruses (RV) are small positive stranded RNA viruses
belonging to the Picornaviridae family. Infection by RV is most
commonly associated with the development of common cold
symptoms. Even though RV infections occur throughout the
year, peak occurrences are reported during early fall and in the
spring from March to May. During these peak periods of RV
infections up to 80% of individuals experiencing common cold
symptoms may be infected with RV (Arruda et al., 1997). In
addition to causing the common cold, RV infections have also
been associated with the development of otitis media, sinusitis,
fever, pneumonia, gastrointestinal symptoms and sepsis in
young children (Couch, 2001; Miller et al., 2007). RV infections
have also recently been associated with the development of more
serious diseases. For example, RV is commonly found in young
children with pneumonia (Abzug et al., 1990; McMillan et al.,
1993) and in some studies RV infections have been associated⁎ Corresponding author. Fax: +1 208 885 7036.
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doi:10.1016/j.virol.2008.01.022with 60%–70% of asthma exacerbations in young children
(Johnston et al., 1995; Rakes et al., 1999).
Infection by many viruses results in the recognition of viral
double-stranded RNA (dsRNA) by cellular pattern recognition
receptors like Toll like receptor 3 (TLR3), melanoma differentia-
tion-associated gene 5 (MDA5) and retinoic acid inducible gene-I
(RIG-I). This leads to the activation of innate host defense
pathways that results in the production of type I interferons. TLR3
signals through the adapter protein TRIF while MDA5 and RIG-I
signal through the adapter protein IPS-1 (also known as Cardiff,
VISA or MAVS) to activate the type I interferon response
(reviewed in Keller et al., 2007). Signaling from these pattern
recognition receptors results in the activation of the cellular
transcription factors NF-κB, IRF-3 and ATF-2, which in
conjunction with the transcriptional coactivators p300/CBP
activate transcription from the IFN-β promoter (Biron and Sen,
2001). Secreted IFN-β then acts in an autocrine or paracrine
fashion to amplify the response by binding to the type I IFN
receptor and activating the Jak/STAT signaling cascade (reviewed
in Samuel, 2001). Ultimately this results in the production of IFN-
α and a variety of immunomodulatory and anti-viral proteins
Fig. 1. RV14 infection of A549 cells fails to induce a type I interferon response.
A. IFN-βmRNA levels in infected cells. Total RNAs extracted from uninfected,
RV14 or Vesicular stomatitis virus-infected cells (VSV) at the indicated times
post-infection were analyzed by qRT-PCR with primers for both IFN-β and
β-actin mRNAs. The amount of IFN-βmRNAwas normalized to the amount of
β-actin mRNA. The induction of IFN-βmRNA relative to uninfected controls is
shown on a log2 scale (a difference of 1 on the y-axis represents a doubling of
mRNA levels). Error bars indicate the standard error of the results from three
biological replicates. hpi: hours post infection. B. Viral RNA levels in infected
cells. Total RNAs were extracted from uninfected or RV14-infected cells at an
MOI of 10 at the indicated times post-infection and analyzed by qRT-PCR with
primers for both RV14 and β-actin mRNAs. RV14 RNA copy number was
determined from the standard curve obtained from the qPCR of serial dilutions of
plasmid having the complete RV14 RNA genome. The amount of RV14 RNA
was normalized to the amount of β-actin mRNA using 4 hpi as reference. Values
on the y-axis are expressed after log10 transformation. The data represents viral
RNA levels from a representative experiment. hpi: hours post infection.
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nylate synthetase that significantly impede viral replication.
Experiments done in the 1970s with RV-infected HeLa cells
showed that rhinovirus did not induce significant amounts of
type I interferon and indicate that RV infection does not elicit an
interferon response in this cell type (Stoker, Kiernat, and Gauntt,
1973). More recent work, however, has indicated that this is not
always the case and that in some situations rhinovirus infection
may induce a type I interferon response. For example, Wark
et al., showed that infection of primary bronchial epithelial cell
cultures resulted in significant production of IFN-β (Wark et al.,
2005). In addition, microarray analysis of the host transcriptional
response to both RV16 and RV1B in primary bronchial epithelial
cells revealed that a variety of interferon stimulated genes were
upregulated following infection and that this transcriptional
response could be reduced with neutralizing antibody to IFN-β
(Chen et al., 2005). However, the observation that only 5% of the
cells in these cultures were infected makes it difficult to ascertain
whether these results represent the transcriptional response of
infected or uninfected cells (Chen et al., 2005).
Infection by RV results in the transcriptional induction of a
number of host gene products. For example, the ICAM-1 and
LDL receptors, which are the cell surface receptors used bymajor
and minor group RV, respectively, are upregulated following
infection (Papi and Johnston, 1999b; Suzuki et al., 2001). In
addition, a number of proinflammatory cytokines including GM-
CSF, IL-8, IL-6 and RANTES are induced following infection by
RV (Edwards et al., 2007; Einarsson et al., 1996; Schroth et al.,
1999; Subauste et al., 1995; Terajima et al., 1997; Zhu et al.,
1997; Zhu et al., 1996). Work from a number of laboratories has
shown that induction of these gene products is due, at least in part,
to the activation of NF-κB, which occurs following infection
(Edwards et al., 2007; Kim et al., 2000; Papi and Johnston,
1999a; Papi and Johnston, 1999b; Zhu et al., 1997; Zhu et al.,
1996). Recently, it was reported that exposure of alveolar
macrophages to RV16 results in activation of ATF-2 (Hall et al.,
2005). As RV16 does not replicate in alveolar macrophages
(Gern et al., 1996), it is not clear if ATF-2 is activated in
productively infected cells. Although these results indicate that
RV infection can activate both NF-κB and ATF-2, the status of
IRF-3 in RV-infected cells has not been examined.
In this study, using the major group rhinovirus type 14 (RV14)
as a model serotype we have examined the type I interferon
response and status of IRF-3 following infection of a lung alveolar
epithelial cell line. Our results indicated that RV14 infection does
not induce high levels of IFN-β mRNA in these cells and that
IRF-3 is not activated following infection. Interestingly, inhibition
of viral protein synthesis resulted in an increase in IFN-βmRNA
levels suggesting that a virally encoded factor is necessary to
prevent activation of the type I interferon response.
Results
RV14 infection fails to induce interferon-β mRNA synthesis
To understand the host type I interferon response to rhinovirus
infection we have investigated the induction of IFN-β mRNA inRV14-infected A549 cells (a lung alveolar epithelial cell line).
Quantitative real-time PCR (qRT-PCR) analysis of RNAs
isolated from RV14-infected cells showed only a 1.2 fold
increase (log2=0.26) in IFN-βmRNA levels at 4 h post infection
(hpi) and by 7 hpi levels were indistinguishable from mock-
infected controls (Fig. 1). Very similar results were obtained
when cells were infected at an MOI of 10 and under these
conditions even at later times levels of IFN-β mRNA were
undetectable (data not shown). As expected, viral RNA levels
increased from 4 to 7 hpi indicating that the virus was actively
replicating in these cells at these times (Fig. 1B). As a positive
control and to illustrate the minimal induction observed in RV14-
infected cells, we infected cells with Vesicular stomatitis virus
(VSV) a known inducer of IFN-β mRNA and the type I IFN
response (tenOever et al., 2004). As shown in Fig. 1, VSV
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193,000 fold (log2=17.6) compared to mock-infected controls.
This data demonstrates that RV14 infection of A549 cells does
not induce the accumulation of IFN-β mRNA. As many viruses
are known to inhibit this response by targeting essential
transcription factors such as NF-κB, IRF-3 and ATF-2, we
focused our attention on the analysis of these factors in RV14-
infected cells.
Activation of NF-κB, ATF-2 and IRF-3 in RV14-infected cells
To understand the lack of induction of IFN-β mRNA upon
RV14 infection, the activation status of NF-κB, ATF-2 and IRF-
3 was examined. NF-κB normally resides in the cytoplasm, but
following infection by many viruses NF-κB is activated and
rapidly accumulates in the nucleus (Pahl, 1999; Yoneyama,
Suhara, and Fujita, 2002). ATF-2 is found in the nucleus at
steady state and activation requires phosphorylation on amino
acids Thr69 and Thr71 (van Dam et al., 1995). Following
activation, these transcription factors bind to promoters of target
genes and induce mRNA synthesis.Fig. 2. Analysis of the status of NF-κB in RV14-infected A549 cells. A. Subcellular
RV14 or VSV for the indicated amount of time were analyzed by immunofluorescence
cells stained with a rabbit polyclonal antibody to detect the p65 subunit of NF-κB us
Hoechst to reveal the nuclei. All images were acquired with identical exposure times
VSV-infected cells at the indicated times post-infection were analyzed by qRT-PCR w
normalized to the amount of β-actin mRNA and its induction relative to uninfected co
from three biological replicates. hpi: hours post infection.To confirm that rhinovirus infection resulted in activation of
NF-κB we examined the subcellular localization of NF-κB and
the levels of IL-6 mRNA, which requires activated NF-κB for
induction (Zhu et al., 1996). Fig. 2A shows that, as expected, NF-
κB is cytoplasmic in mock-infected cells and that by 5 hpi it is
predominantly nuclear, suggesting that NF-κB is activated
following infection with rhinovirus. To confirm that the
translocated NF-κB is functionally active in infected cells, the
level of induction of IL-6 was examined. Fig. 2B shows that IL-6
mRNA levels are significantly upregulated at 4 and 7 hpi
confirming that NF-κB is activated in rhinovirus-infected cells.
As expected for a virus that activates the IFN-β promoter VSV
infection also resulted in the nuclear translocation ofNF-κBand a
strong induction of IL-6 mRNA (Figs. 2A and 2B, respectively).
These observations are in agreement with numerous reports that
NF-κB is activated following rhinovirus infection (Edwards
et al., 2007; Kim et al., 2000; Papi and Johnston, 1999a; Papi and
Johnston, 1999b; Zhu et al., 1997; Zhu et al., 1996).
To determine if ATF-2 is activated in RV14-infected A549
cells, we utilized a phospho-specific antibody that reacts only
with activated ATF-2. As expected, very little phospho-ATF-2distribution of NF-κB. Cells that were mock-infected or had been infected with
with antibodies to detect the p65 subunit of NF-κB. Panels labeled NF-κB show
ing FITC filter, while the panels labeled DNA show the same fields stained with
. B. Induction of IL-6 mRNA. Total RNAs extracted from uninfected, RV14 or
ith primers for both IL-6 and β-actin mRNAs. The amount of IL-6 mRNAwas
ntrols is shown on a log2 scale. Error bars indicate the standard error of the results
Fig. 4. Analysis of the status of IRF-3 in RV14-infected A549 cells. Total RNAs
extracted from uninfected, RV14 or VSV-infected cells at the indicated times
post-infection were analyzed by qRT-PCR with primers for both interferon
stimulated gene 54 (ISG54) and β-actin mRNAs. The amount of ISG54 mRNA
was normalized to the amount of β-actin mRNA and its induction relative to
402 S. Kotla et al. / Virology 374 (2008) 399–410was present in mock-infected cells consistent with ATF-2 being
in an inactivated state (Fig. 3A, lane 1). Four hours after
infection with RV14 phospho-ATF-2 was readily detected and
levels remained elevated through 7 h post infection (Fig. 3A,
lanes 2 and 3). This was not due to an overall increase in ATF-2
protein levels, as the total amount of ATF-2 present in RV14-
infected cells did not increase (Fig. 3A, compare lanes 1–3). As
expected, activation of the type I IFN response by treatment
with poly(I:C) also resulted in an increase in phospho-ATF-2
levels (Fig. 3A, lane 5). To confirm that the phosphorylated
ATF-2 seen in infected cells is functionally active, the level
of induction of an ATF-2 responsive transcript, monocyte
chemoattractant protein 1 (MCP-1), was examined (Hall et al.,
2005). Fig. 3B shows that MCP-1 mRNA is induced 8.2 fold
(log2=3.04) by 4 hpi and that levels remain high through 7 hpi.
Surprisingly, despite being strong activators of the type I IFN
response, poly(I:C) treatment (Fig. 3B) and VSV infection (dataFig. 3. Analysis of the status of ATF-2 in RV14-infected A549 cells. A.
Phosphorylation of ATF-2. Whole cell lysates prepared from uninfected, RV14-
infected or poly(I:C) treated cells were analyzed by immunoblotting.
Phosphorylated (phospho-ATF-2) and total ATF-2 (Total ATF-2) forms were
detected by sequentially probing the membrane using antibodies specific for the
indicated forms of ATF-2. The membrane was also probed with an antibody to
β-actin to show equivalent loading of protein lysates. B. Induction of MCP-1
mRNA. Total RNAs extracted from uninfected, RV14-infected or poly(I:C)
treated cells at the indicated times post-infection were analyzed by qRT-PCR
with primers for both monocyte chemoattractant protein-1 (MCP-1) and β-actin
mRNAs. The amount of MCP-1 mRNA was normalized to the amount of β-
actin mRNA and its induction relative to uninfected controls is shown on a log2
scale. Error bars indicate the standard error of the results from three biological
replicates for RV14-infected cells. The average of two biological replicates for
poly(I:C) treated cells is shown. hpi: hours post infection.
uninfected controls is shown on a log2 scale. Error bars indicate the standard
error of the results from three biological replicates. hpi: hours post infection.not shown) resulted in only a slight induction of MCP-1 mRNA
levels. The phosphorylation of ATF-2 along with the induction
of MCP-1 mRNA levels in RV14-infected A549 cells indicates
that ATF-2 is activated and functional following infection.
To determine if IRF-3 was activated, we investigated the
transcriptional induction of interferon stimulated gene 54
(ISG54), which is dependent upon IRF-3 activation for
induction (Cheng et al., 2006). Fig. 4 shows that by 7 hpi
only a 2.6 fold (log2=1.37) increase in ISG54 mRNA levels
was seen in RV14-infected cells. In contrast, infection with
VSV, a potent activator of IRF-3 and the type I IFN response
resulted in a 4500 fold (log2=12.14) induction of ISG54. The
low levels of IFN-β and ISG54 mRNAs, despite activation of
NF-κB and ATF-2 suggest that IRF-3 activation may be
impaired in RV14-infected cells.
Status of IRF-3 in RV14-infected cells
IRF-3 plays a central role in activating the type I interferon
response following viral infection. Consequently, many viruses
are known to target IRF-3 to inhibit the type I interferon re-
sponse pathway (Baigent et al., 2002; Foy et al., 2003; Lin et al.,
2004; Spiegel et al., 2005; Talon et al., 2000). Following viral
infection IRF-3 gets phosphorylated at specific serine residues
in the C-terminus (Lin et al., 1998; Weaver, Kumar, and Reich,
1998; Yoneyama et al., 1998). Phosphorylated IRF-3 forms a
homodimer, translocates to the nucleus and associates with the
transcriptional co-activators p300/CBP prior to binding to target
DNA elements and inducing transcription (Suhara et al., 2002).
In view of this, we investigated the subcellular distribution,
dimerization and phosphorylation status of IRF-3 in RV14-
infected A549 cells.
To determine if infection of A549 cells with RV14 resulted in
the nuclear accumulation of IRF-3 we examined cells by indirect
immunofluorescence assay. When mock-infected cells were
stained with antibody to IRF-3 (Yoneyama et al., 1998) very
little signal was observed (Fig. 5A). In contrast, examination of
Fig. 5. Subcellular localization, dimerization and phosphorylation status of IRF-3 in RV14-infected A549 cells. A. Subcellular distribution of IRF-3. Cells that were
mock-infected or had been infected with RV14 or VSV for the indicated amount of time were analyzed by immunofluorescence with antibodies to IRF-3. Panels
labeled IRF-3 shows cells stained with a rabbit polyclonal antibody to detect IRF-3 using a FITC filter, while the panels labeled DNA show the same fields stained with
Hoechst to reveal the nuclei. The bottom panel shows phase contrast images of the corresponding fields (Phase). B. Homodimerization of IRF-3. Whole cell lysates
prepared from cells that were mock-infected or had been infected with RV14 or VSV for the indicated amount of time were analyzed by native PAGE followed by
immunoblot to detect IRF-3. The monomeric and dimeric forms of IRF-3 are indicated. C. Phosphorylation of IRF-3. Whole cell lysates prepared from cells that were
mock-infected or had been infected with RV14 or VSV for the indicated amount of time were analyzed by immunoblotting with a rabbit polyclonal antibody that
detects IRF-3. Different forms of IRF-3 are indicated (I, II, III, IV). The membrane was stripped and reprobed with an antibody to β-actin to show equivalent loading of
protein lysates.
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staining that was restricted to the nucleus, indicating that IRF-3
was activated and translocated to the nucleus in these cells. The
reason why this antibody reacts poorly with inactive /cyto-
plasmic IRF-3 in unstimulated A549 cells is not known. A
similar analysis of IRF-3 in HeLa cells revealed strong
cytoplasmic staining in uninfected cells (Iwamura et al., 2001
and data not shown). Although some of the staining seen in the
nucleus of VSV-infected A549 cells may be due to increased
levels of IRF-3 (Fig. 5B,C) our finding that poly(I:C) treatment
resulted in the nuclear accumulation of IRF-3 without a
concomitant increase in protein levels (data not shown) suggests
that this antibody may react preferentially with activated IRF-3
in A549 cells. When RV14-infected cells were examined withthis antibody at 5 hpi a staining pattern that was indistinguish-
able frommock-infected cells was seen, suggesting that IRF-3 is
not activated and translocated to the nucleus following RV14
infection.
To determine the dimerization status of IRF-3 in RV14-
infected cells, we examined the status of IRF-3 by native PAGE
followed by immunoblot. Under these conditions, dimerized
IRF-3 has significantly retarded mobility compared to mono-
meric IRF-3 (Iwamura et al., 2001). Analysis of lysates from
RV14-infected cells revealed that there was no detectable IRF-3
homodimer at 4 or 7 hpi (Fig. 5B). In contrast, VSV infection
results in a robust induction of IRF-3 homodimer formation
(Fig. 5B). These results indicate that RV14 infection does not
result in the nuclear translocation or dimerization of IRF-3.
Fig. 6. Induction of IFN-β mRNA in the absence of protein synthesis. A549
cells were either mock-infected or infected with RV14 at different multiplicities
of infection (MOI) and then treated or not with 100 μg/ml of cycloheximide.
Total RNA's were isolated at 7 hpi and analyzed by qRT-PCR with primers for
both IFN-β and β-actin mRNAs. The amount of IFN-β mRNAwas normalized
to the amount of β-actin mRNA and the induction of IFN-β mRNA relative to
uninfected controls is shown on a log2 scale. Error bars indicate the standard
error of the results from three biological replicates.
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pressed as forms I and II due to alternate splicing of the IRF-3
pre-mRNA (Karpova, Howley, and Ronco, 2000; Karpova,
Ronco, and Howley, 2001). Work in other laboratories has
shown that phosphorylation of IRF-3 results in the appearance
of slower migrating forms that are detectable by immunoblot
(Lin et al., 1998; tenOever et al., 2004; Weaver, Kumar, and
Reich, 1998). Upon activation by viral infection the slower
migrating forms III and IV appear due to phosphorylation of
IRF-3 on multiple residues (tenOever et al., 2004). Analysis of
lysates from mock-infected A549 cells revealed approximately
equivalent amounts of both IRF-3 forms I and II (Fig. 5C).
Following infection with VSV the amount of forms I and II
decreases while the amount of the slower migrating forms III
and IV increases (Fig. 5C). These results are in agreement with
previously published work and indicate that IRF-3 was phos-
phorylated following infection with VSV (tenOever et al.,
2004). Analysis of lysates from RV14-infected cells did not
reveal the presence of forms III and IV indicating that IRF-3 was
not phosphorylated to a significant extent in these cells. One
subtle difference that was apparent in RV14-infected cells,
particularly at 4 hpi, was that the amount of form I appeared to
be reduced compared to mock-infected cells, while the amount
of form II was increased (Fig. 5C). This difference was still
apparent, although less evident by 7 hpi. These subtle differ-
ences in the abundance of IRF-3 forms I and II in RV-14
infected cells were consistently observed in multiple indepen-
dent experiments. Although the significance of these changes is
not known, it may be due to degradation of form I along with the
increased synthesis or stability of form II, or due to the mod-
ification, perhaps by limited phosphorylation, of form I such
that it comigrates with form II. The findings that IRF-3 induced
transcripts are not upregulated, that IRF-3 is not translocated to
the nucleus, not phosphorylated and does not dimerize indicate
that IRF-3 is not activated following infection with RV14.
Role of protein synthesis in the inhibition of IFN-β mRNA
induction
Many viruses overcome the host antiviral response through
the expression of gene products that antagonize the type I
interferon response (Basler and Garcia-Sastre, 2002; Garcia-
Sastre, 2004). Similarly, the lack of induction of IFN-β mRNA
in RV14-infected cells could be mediated by viral proteins. If
this were the case, then preventing viral protein synthesis
following infection should result in the production of increased
levels of IFN-β mRNA. To test this possibility, cells were
infected with RV14 and then treated with cycloheximide to
inhibit viral protein synthesis and analyzed by qRT-PCR for the
induction of IFN-β mRNA. Fig. 6 shows that, as expected, in
cells infected for 7 h with RV14 at an MOI of 10 or 100, levels
of IFN-β mRNA were very low. In contrast, when protein
synthesis was inhibited by the addition of cycloheximide a
modest increase in the induction of IFN-β mRNA was ob-
served. Interestingly, infection of cells in the presence of
cycloheximide at an MOI of 100 resulted in a slightly greater
induction of IFN-β mRNA than did infection at an MOI of 10.Statistical analysis of this difference indicated that it was
marginally statistically significant with a P value of 0.0528.
Although the reason for this difference is not clear, it may reflect
the larger amount of viral RNA introduced into cells infected at
an MOI of 100 as opposed to anMOI of 10. Surprisingly, we did
not detect IRF-3 dimerization in cells infected and treated with
cycloheximide (data not shown). While we do not know the
reason for this, it may be that IRF-3 dimer levels sufficient to
induce the modest increase in IFN-β mRNA levels shown in
Fig. 6 are below the level of detection provided by
immunoblotting. These results are consistent with the idea
that the lack of induction of IFN-β mRNA in RV14-infected
cells is mediated, at least in part by viral gene products.
Status of MDA5 and IPS-1 in RV14-infected cells
Recent work has suggested that picornaviruses can disrupt
the type I interferon response by causing the degradation of key
signaling molecules. For example, Barral et al., showed that
MDA5 is degraded in cells infected with poliovirus and certain
rhinovirus serotypes (Barral et al., 2007). Similarly, the 3ABC
precursor of hepatitis A virus prevents IRF-3 activation by
cleaving the mitochondrial signaling molecule IPS-1 (Yang
et al., 2007). As the results from the cycloheximide experiment
above (Fig. 6) suggested a role for viral gene product/s in
preventing induction of IFN-β mRNA, we examined the
possibility that this was due to degradation of MDA5 or IPS-1.
Unfortunately, endogenous levels of MDA5 in A549 cells were
undetectable by immunoblot analysis using available antibodies
(Fig. 7A, lanes 1–3). Consistent with this, only low levels of
MDA5 mRNAwere detected in both mock and RV14-infected
cells (data not shown). Barral et al., encountered a similar
situation in HeLa cells and found that MDA5 protein levels
could be induced by treating cells with poly(I:C) for 16 h
(Barral et al., 2007). Similar treatment of A549 cells resulted in
Fig. 8. Induction of the dsRNA response in RV14-infected cells. A549 cells
were either mock-infected or infected with RV14 and then treated with 100 μg/
ml of poly(I:C) or not for 2.5 h. Total RNA's were isolated at 4 hpi and analyzed
by qRT-PCR with primers for both IFN-β and β-actin mRNAs. The amount of
IFN-βmRNAwas normalized to the amount of β-actin mRNA and its induction
relative to uninfected controls is shown on a log2 scale. Error bars indicate
standard error of the results from three biological replicates.
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following infection with RV14 (Fig. 7A, lanes 4–6). Analysis of
the steady state levels of IPS-1 revealed a slight increase at 4 hpi,
however, by 7 hpi levels of IPS-1 had returned to the level seen in
mock-infected cells (Fig. 7B). These results indicate that RV14
does not inhibit the type I interferon response by targeting
MDA5 or IPS-1 for proteolysis.
The response to dsRNA in RV14-infected cells
Poly(I:C) is a synthetic analogue of double-stranded RNA
(dsRNA) as evidenced by the activation of IRF-3 and the
induction of IFN-βmRNA (Raj and Pitha, 1980;Weaver, Kumar,
and Reich, 1998; Yoneyama et al., 1998). Interestingly, Dodd and
Kirkegaard found that infectionwith poliovirus inhibits the ability
of cells to produce IFN-β mRNA in response to treatment with
poly(I:C) (Dodd, 2002). In addition, Richsteiger et al., reported
that infection of cells with Coxsackievirus B3 followed by poly(I:
C) treatment resulted in a 32% inhibition of IFN-β mRNA
induction compared to cells treated with poly(I:C) alone
(Richtsteiger et al., 2003). To determine if infection with RV14
can similarly inhibit the induction of IFN-β, A549 cells were
infected with RV14 and then treated with poly(I:C) at 1.5 h post
infection. Two and a half hours later total RNAwas prepared and
analyzed by qRT-PCR to determine the level of IFN-β mRNAFig. 7. Steady state levels of MDA5 and IPS-1. A. MDA5 analysis. Whole cell
lysates prepared from cells that were either untreated or treated with poly(I:C)
(100 μg/ml) for 16 h and then mock-infected or infected with RV14 for the
indicated amount of time were analyzed by immunoblotting with a rabbit
polyclonal antibody that detects MDA5. The membrane was stripped and
reprobed with an antibody to β-actin to show equivalent loading of protein B.
IPS-1 analysis. Whole cell lysates prepared from cells that were mock-infected
or had been infected with RV14 for the indicated amount of time were analyzed
by immunoblotting with a rabbit polyclonal antibody that detects IPS-1. The
membrane was stripped and reprobed with an antibody to β-actin to show
equivalent loading of protein lysates. Band intensities were quantified by
densitometry and IPS-1 levels were normalized to β-actin. IPS-1 levels relative
to mock-infected cells are indicated.induction. Fig. 8 shows that poly(I:C) treatment alone resulted in a
910 fold (log2=9.8) induction of IFN-βmRNA.As shown above,
infection with RV14 for 4 h results in a very slight induction of
IFN-β (log2=3). Surprisingly, the addition of poly(I:C) to cells
that had been infectedwithRV14 resulted in the induction of IFN-
β mRNA to levels similar to those seen in cells treated with poly
(I:C) alone (Fig. 8). This was not due to the timing of poly(I:C)
addition as similar results were obtained when poly(I:C) was
added at 4.5 h post infection and total RNAwas isolated at 7 hpi
(data not shown). In addition, these results were not unique to
A549 cells as an analysis of HeLa cells infected with RV14 and
treated with poly(I:C) revealed very similar results (data not
shown). The finding that RV14 infection does not interfere with
poly(I:C) mediated signaling raises the possibility (discussed
below) that viral infection and poly(I:C) treatment mediate
activation of the IFN-β promoter through distinct pathways.
Discussion
In this study we have examined the type I IFN response and
the status of IRF-3 in RV14-infected A549 cells. The results
demonstrate that RV14 infection does not induce a strong type I
IFN response as evidenced by very low levels of IFN-βmRNA.
Analysis of the transcription factors required for activation of
the IFN-β promoter revealed that both NF-κB and ATF-2 were
activated following infection. In contrast, the inability to detect
phosphorylation, homodimer formation or nuclear accumula-
tion of IRF-3 indicates that this transcription factor is not
activated in RV14-infected cells. Consistent with these results,
very little induction of the IRF-3 dependent ISG54 promoter
was seen in infected cells. The lack of activated IRF-3 despite
strong activation of NF-κB and ATF-2 raises the possibility that
RV14 may prevent IRF-3 activation to inhibit the induction of
IFN-β mRNA and the type I IFN response. The finding that
inhibition of viral protein synthesis by cycloheximide resulted
in an increase in the levels of IFN-β mRNA suggests that RV14
406 S. Kotla et al. / Virology 374 (2008) 399–410may inhibit this response via the action of virally encoded gene
products.
Our analysis revealed very low levels of IFN-β mRNA in
infected cells (Fig. 1) suggesting that in A549 cells RV14 does
not elicit a strong type I IFN response. This is in agreement with
experiments by Stoker et al., demonstrating that HeLa cells
infected with RV14 produce little type I interferon (Stoker,
Kiernat, and Gauntt, 1973). However, recent experiments
indicate that this may not always be the case. Examination of
primary bronchial epithelial cells from healthy individuals
revealed that a significant amount of IFN-β mRNA and protein
was produced following infection with rhinovirus type 16
(Wark et al., 2005). Another study reported the upregulation of a
variety of interferon stimulated genes and activation of a type I
interferon response in primary bronchial epithelial cells infected
with RV16 and RV1B (Chen et al., 2005). Interestingly, very
little IFN-β was produced when bronchial epithelial cells from
asthmatic individuals were infected with RV16 (Wark et al.,
2005). Currently it is not clear if the differences between the
results presented here for RV14 and those described above for
RV16 and RV1B are due to differences between serotypes or the
use of primary vs. immortalized cell lines.
Transcriptional activation of the IFN-β promoter requires the
activation of NF-κB, ATF-2 and IRF-3 (Biron and Sen, 2001).
The results presented here indicate that both NF-κB and ATF-2
become activated and are functional in RV14-infected A549
cells and are consistent with previous reports showing
activation of NF-κB and ATF-2 in RV-infected cells (Edwards
et al., 2007; Hall et al., 2005; Kim et al., 2000; Papi and
Johnston, 1999a; Papi and Johnston, 1999b; Zhu et al., 1997;
Zhu et al., 1996). Interestingly, Neznanov et al., reported that
the p65/RelA subunit of NF-κB is cleaved in RV14-infected
HeLa cells providing a possible mechanism to attenuate the type
I IFN response. However, as cleavage of p65/RelA was not
apparent until 8 h post infection (Neznanov et al., 2005) it seems
unlikely that this contributes to the lack of IFN-β mRNA
production at early times in RV14-infected cells.
In contrast to NF-κB and ATF-2, IRF-3 did not appear to be
activated in RV14-infected cells. This observation provides an
explanation for the low levels of IFN-β mRNA in infected cells
and suggests that RV14 infection may interfere with the
activation of IRF-3. Blocking the type I interferon response by
interfering with the activation of IRF-3 is a common strategy
used bymany viruses including picornaviruses. For example, the
3ABC precursor of hepatitis A virus prevents IRF-3 activation
by cleaving the mitochondrial signaling molecule IPS-1(Yang
et al., 2007). Similarly, poliovirus along with rhinovirus type 1a
and encephalomyocarditis virus were recently found to induce
cleavage of the cytosolic helicaseMDA5 in a caspase-dependent
manner. Surprisingly, when MDA5 cleavage was prevented by
adding caspase inhibitors to infected cells no increase in IFN-β
mRNA levels was observedmaking it unclear ifMDA5 cleavage
contributes to evasion of the type I IFN response in poliovirus-
infected cells (Barral et al., 2007). In addition, no degradation of
MDA5 was apparent in cells infected with RV16. Although no
proteolysis of either MDA5 or IPS-1 was seen in RV14-infected
cells it is still possible that RV14 inhibits the activities associatedwith MDA5 and/or IPS-1 to prevent the activation of IRF-3.
Alternatively, RV14 could be interfering with the activities of
other signaling molecules in this pathway. Whatever the cellular
target, our finding that a protein synthesis inhibitor at least
partially relieves this inhibition suggests that viral factors have a
role.
Given the lack of IRF-3 activation in RV14-infected cells, the
finding that infection with RV14 did not attenuate the cell's
ability to respond to dsRNAwas surprising and is in contrast to
similar experiments done with other picornaviruses. For ex-
ample, infection with poliovirus or Coxsackievirus B3 inhibits
the ability of cells to produce IFN-β mRNA in response to
treatment with dsRNA (Dodd, 2002; Richtsteiger et al., 2003).
One possible explanation for the results presented here is that
rather than actively inhibiting the type I IFN response, RV14
simply fails to activate it. In other words, the cell simply does not
‘see’ the virus and the cellular pathways remain functional.
Although this is certainly possible, the observation that both NF-
κB and ATF-2 are activated indicates that the cells are capable of
sensing and responding to viral infection at least to some degree.
Another possible explanation for these results is that RV14
specifically attenuates the pathway used by the cell to sense and
respond to RV infection without disrupting other dsRNA-
responsive pathways. The finding that deletion of MDA5 but
not RIG-I makes mice more susceptible to infections with
encephalomyocarditis virus (EMCV) indicates that MDA5 may
be the pattern recognition receptor that recognizes and responds
to picornaviruses (Kato et al., 2006). Also, as mentioned above,
recent work has shown that several picornaviruses, including
some rhinovirus serotypes cause the degradation of MDA5
(Barral et al., 2007). In this scenario, disrupting the function of
MDA5 could prevent the cell from activating IRF-3 in response
to rhinovirus infection but would not interfere with its activation
via RIG-I or TLR3. Although a recent report indicated that poly
(I:C) is sensed primarily by MDA5 (Kato et al., 2006), other
studies indicate that both TLR3 and RIG-I can initiate signaling
in response to poly(I:C) stimulation (Alexopoulou et al., 2001;
Yoneyama et al., 2005). As A549 cells do not express high
levels of TLR-3 (Tissari et al., 2005), it seems likely that
recognition of poly(I:C) by RIG-I was responsible for the
induction of IFN-β mRNA seen in RV-14 infected cells. If this
is the case it would indicate that factors common to both RIG-I
and MDA5 signaling, such as IPS-1, the IRF-3 kinases IKKɛ/
TBK1 and IRF-3 are not direct targets of rhinovirus-mediated
inhibition. Experiments are under way to further delineate the
mechanism/s by which RV14 prevents IRF-3 activation and to
identify the viral factor/s responsible.
Materials and methods
Cell culture and virus
A549 cells, a human lung alveolar epithelial cell line, were
purchased from ATCC and cultured in F-12 K medium
(Invitrogen) supplemented with 10% Fetal Bovine Serum (FBS),
and Penicillin–Streptomycin at 37 °C in 5%CO2. Rhinovirus type
14 (RV14) strain 1059was obtained fromATCC (VR-284) and the
407S. Kotla et al. / Virology 374 (2008) 399–410specificity of the virus was confirmed by RT-PCR and RV14-
specific antisera from ATCC (VR-284AS/RB). Viral stocks were
prepared as described previously (Gustin and Sarnow, 2002).
Vesicular stomatitis virus (VSV) was a gift from Dr. Troy L. Ott at
Pennsylvania State University. Sub-confluent A549 cells were
either mock-infected or infected with RV14 or VSV at a
multiplicity of infection (MOI) of 50. Virus was adsorbed for
30min at 32 °C in phosphate-buffered saline (PBS) supplemented
with 1 mM MgCl2 and 1 mM CaCl2 (RV14) or 1 h at 37 °C in
DMEM (VSV). Following adsorption, residual virus was removed
and F-12 K medium with 10% FBS and Penicillin–Streptomycin
was added. Where indicated, 100 μg/ml cycloheximide (Calbio-
chem, 239763) was added 30min following infection and the cells
were incubated for the indicated amount of time.
RNA isolation and cDNA synthesis
Mock and infected cells were incubated for the indicated
amounts of time and total RNA was prepared using the Qiagen
RNeasy mini kit (Qiagen; 74104). To remove any traces of
contaminating DNA, on column DNA digestion was carried out
using RNase-Free DNase set (Qiagen; 79254) as described by the
manufacturer. The quantity and integrity of RNA was assessed
using a Nanodrop spectrophotometer (ND-1000). Onemicrogram
of total RNA was reverse transcribed to cDNA using the Su-
perscript III First-Strand Synthesis System for RT-PCR (Inviro-
gen; 18080-051). No-RTcontrols were also processed in the same
way as cDNA samples without the Superscript III enzyme.
Quantitative real-time PCR (qRT-PCR)
Either 0.2 or 0.4 percent of the total cDNA volume was used
in a SYBR green PCR assay (New England Biolabs; F-410l).
PCR was performed on a 7500 Fast Real-Time PCR System
(Applied Biosystems). The following PCR cycling conditions
were used for amplifying IFN-β: first step, 50 °C for 2′; second
step 95 °C for 10′; third step, 35 cycles of 94 °C for 10″, 59 °C
for 30″, 72 °C for 45″and 75 °C for 29″; fourth step,
dissociation step. For all other genes the following PCR cycling
conditions were used: first step, 50 °C for 2′; second step 95 °C
for 10′; third step, 35 cycles of 94 °C for 10″, 60 °C for 30″
and 72 °C for 30″; fourth step, dissociation step. For the
amplification of viral RNA annealing and extension conditions
were 56 °C for 30″ and 72 °C for 45″, respectively. The
specificity of amplification for each gene was confirmed by
agarose gel electrophoresis, melting curve analysis and sequen-
cing analysis. The cycle threshold (Ct) for each gene wasTable 1
Primer sequences for qRT-PCR analysis






RV14 K02121 GATCAGGTGGATTTTCCCTCdetermined by setting the Ct line at the center of the logarithmic
phase of amplification for that particular gene. The Ct differences
between mock-infected and virus-infected samples (triplicates)
were calculated using the delta delta Ct method (Livak and
Schmittgen, 2001). Primer sets used for the amplification of
different genes are indicated in Table 1. The primer sequences for
IFN-β (Spann et al., 2004) and β-actin (Barral et al., 2007) were
obtained from the literature. Primers for the remaining genes
were designed based on available sequence data.
Immunoblotting
A549 cell lysates were prepared by scraping cells into PBS
followed by centrifugation at 200 ×g for 5 min and resuspended
in Tx lysis buffer (50 mM triethanolamine [pH 7.4]; 500 mM
NaCl; 0.5% Triton X-100; 1 mM dithiothreitol) containing 1×
protease and phosphatase inhibitor cocktail (Calbiochem,
539134 and Sigma, P2850 respectively). Following a 20 min
incubation on ice the lysates were centrifuged at 16,000 ×g for
5 min and the pellet was discarded. Protein quantification was
determined using the Bio-Rad protein assay kit. Equal
quantities of the protein were separated on SDS-8% PAGE to
examine ATF-2 and IPS-1, 10% PAGE to examine MDA5 and
12% PAGE to examine IRF-3 followed by transfer to a PVDF
membrane (Millipore Corporation). Phosphorylated ATF-2 and
total ATF-2 were detected using rabbit polyclonal and rabbit
monoclonal antibodies, respectively (Cell Signaling). Rabbit
polyclonal antibodies were used to detect IPS-1 (Axxora, ALX-
210–929), MDA5 (Lin et al., 2006), IRF-3 (Santa Cruz
Biotechnology, sc-9082) and β-actin (Abcam, ab8227). Anti-
body-antigen complexes were detected using an HRP con-
jugated secondary antibody and chemiluminescence.
IRF-3 dimerization assay
Cell lysates were prepared by scraping cells into PBS
followed by centrifugation at 200 ×g for 5 min and resuspension
in native PAGE lysis buffer (50 mM Tris–Cl, pH 8.0, 150 mM
NaCl and 1% NP-40) containing 1× protease and phosphatase
inhibitor cocktail (Calbiochem, 539134 and Sigma, P2850,
respectively). Non-denaturing 7.5% acrylamide gels were pre-
run at 40 mA constant current for 30 min in cathode and anode
buffer at room temperature and equal quantities of proteins were
separated at 25 mA constant current for 50 min at 4 °C (Iwamura
et al., 2001). Proteins were transferred to PVDF membrane at a
constant current of 350 mA for 1 h at 4 °C. IRF-3 monomers and
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HRP conjugated secondary antibody and chemiluminescence.
Immunofluorescence
A549 cells were seeded onto 12 mm diameter coverslips and
48 h later cells were either mock-infected or infected with RV14
or VSV at an MOI of 50. Coverslips were removed at the
indicated times, fixed in 3% formaldehyde for 10 min at 25 °C,
washed three times in PBS and permeabilized in Acetone:
Methanol (1:1) for 2 min at 25 °C. Coverslips were then washed
2 times in PBST (1× PBS with 0.04% Tween 20), incubated in
blocking solution (5 mg/ml BSA in PBST) for 1 h at 25 °C and
incubated overnight at 4 °C in primary antibody against IRF-3
(rabbit polyclonal antibody; a kind gift from Dr. Takashi Fujita,
(Iwamura et al., 2001; Yoneyama et al., 1998). Coverslips were
then washed two times in PBST, incubated for 1 h at 25 °C in
secondary antibody conjugated to Alexafluor 488 (Molecular
probes), washed two times in PBST, stained with Hoechst 33258
(0.2 µg/ml in PBS) and mounted on glass slides with Vectashield
mounting medium. Cells were viewed on a Nikon E1000M
fluorescent microscope at 60× magnification and images were
obtained using a Hamamatsu Orca 285 digital monochrome
camera and Metamorph software (Universal Imaging).
For the subcellular localization of endogenous NF-κB, A549
cells were seeded onto coverslips and infected with RV14 or
VSV as described above. Coverslips were removed at the
indicated times, fixed in 3% formaldehyde for 15 min at 25 °C,
washed three times in PBS and permeabilized in methanol for
5 min at −20 °C. Coverslips were then washed 3 times in PBS,
incubated in blocking solution (2%BSA, 0.05% Triton X-100 in
PBS) for 30 min at 25 °C and incubated overnight at 4 °C in
primary antibody against NF-κB/p65 (Santa Cruz Biotechnol-
ogy, sc-109). Coverslips where then washed three times in
blocking solution, incubated for 1 h at 25 °C in secondary
antibody conjugated to Alexafluor 488 (Molecular probes),
washed two times in PBS, stained with Hoechst 33258 (0.2 µg/
ml PBS) and mounted on glass slides with Vectashield mounting
medium. Images were taken as described above.
Poly(I:C) treatment
A549 cells were seeded in 35 mm wells and 48 h later cells
were either mock-infected or infected with RV14 at an MOI of
50. After 1.5 h cells were transfectedwith 100 μg/ml of poly(I:C)
(Sigma, P0913) using 800 μg/ml of DEAE-dextran (Sigma,
D9885). Mock-treated cells were exposed to DEAE-dextran in
the absence of poly(I:C). After an additional 2.5 h incubation
total RNA was extracted and IFN-β mRNA levels were
quantified by qRT-PCR as described above. To induce MDA5
protein synthesis cells were treated with 100 μg/ml of poly(I:C)
using DEAE-dextran for 16 h.
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